Walgreens discloses DOJ meeting on alleged Controlled Substances violations

Walgreens Boots Alliance (NASDAQ:WBA) discloses (10-Q, page 24) that the company met with the U.S. Department of Justice (DOJ) last month concerning alleged violations of the U.S. Controlled Substances Act and the U.S. False Claims Act. The inquiry relates to prescription dispensing at certain Walgreens locations.Walgreens Boots Alliance (NASDAQ:WBA) discloses (10-Q, page 24) that the company met with the U.S. Department of Justice (DOJ) last month concerning alleged violations of the U.S. Controlled Substances Act and the U.S. False Claims Act. The inquiry relates to prescription dispensing at certain Walgreens locations.

https://seekingalpha.com/news/3590136-walgreens-discloses-meeting-doj-over-alleged-violations-of-controlled-substances-act